Lv1
20 积分 2022-09-05 加入
Implementation of digital health technology in clinical trials: the 6R framework
5小时前
已完结
TQB2440 compared with reference pertuzumab for HER2-positive, ER/PgR-negative, early or locally advanced breast cancer: a multicenter, randomized, double-blind, parallel-controlled, phase III equivalence trial
3个月前
已完结
Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis
10个月前
已完结
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
10个月前
已关闭
皖公网安备34019202002308
